PMC/PubMed Indexed Articles
Indexed In
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
George Kannourakis
Ballarat Oncology and Haematology Services, Ballarat, Australia
Publications
-
Research Article
Low-Dose Palliative Chemotherapy Compared to Standard-Dose Chemotherapy for Poor-Prognosis Cancers Improves Overall Survival - A Single Institution Retrospective Study
Author(s): Andrew Dind, Rebecca Kannourakis, George Kannourakis* and Jarmila Sterbova
Background: Palliative oncology is a balance between maximising quality and quantity of life. Whilst aggressive chemotherapy is associated with severe side effects, low-dose chemotherapy now plays a role in treating many advanced malignancies with palliative intent. There is a need to compare the survival of patients receiving low-dose with standard-dose chemotherapy. Methods: Data collected from Ballarat Oncology and Haematology Services (BOHS) records was retrospectively assessed for patients diagnosed between 2004-2010 with advanced ovarian, lung, colorectal and pancreatic cancers. 166 patients were assessed for their chemotherapy doses, classed as low-dose chemotherapy (n=69) or standard-dose chemotherapy (n=97). Survival was assessed using the Kaplan-Meier method and the difference between the groups assessed using lo.. View more»